Category: Uncategorized

1. Purpose

Proper storage of expressed breast milk (EBM) helps preserve its nutritional and immunological properties for later feeding when the mother is away.

2. Containers for Storage

• Use clean, sterilized glass or BPA-free plastic containers with tight-fitting lids.
• Breast milk storage bags (food-grade, pre-sterilized) are convenient for freezing.
• Avoid ordinary plastic bottles or disposable liners.

3. Labeling

• Each container should be labeled with:
• Date and time of expression
• Baby’s name (if used in hospital or daycare)

4. Storage Guidelines

5. Thawing and Warming

• Thaw in refrigerator overnight or by placing the container in warm water (<37°C).
• Do not microwave or boil — destroys antibodies and nutrients.
• Swirl gently (do not shake) to mix separated fat layers.
• Once thawed, use within 24 hours and do not refreeze.

6. Hygiene

• Wash hands before expressing or handling milk.
• Use clean pump parts and containers for each session.
• Avoid touching the inside of lids or bottles.

7. Key Points

• Always use oldest milk first (“first in, first out”).
• Discard leftover milk from feeding bottle after use.
• Observe for odor or curdling — discard if spoiled.

Summary:

Safe breast milk storage requires hygienic handling, correct temperature, and appropriate duration. Properly stored milk retains most of its nutritional, immunological, and protective properties, ensuring safe feeding for infants when direct breastfeeding isn’t possible.

MD-Level Note: Steroid Dosing in Nephrotic Syndrome

checking oedema in nephrotic syndrome

1. Standard (First Episode) Nephrotic Syndrome

Guideline Reference:

• KDIGO 2021 Glomerular Disease Guideline

• IPNA Consensus 2021

• Nelson Textbook of Pediatrics (22nd ed., Ch. 494, p. 2570)

Dose:

Prednisolone 2 mg/kg/day (maximum 60 mg/day) for 6 weeks, followed by
1.5 mg/kg on alternate days (maximum 40 mg) for next 6 weeks.

Rationale:

• Earlier protocols (e.g., 4+4 week or 8-week total) are less effective.

• Prolonged 12-week regimen (6+6) gives fewer relapses.

Practical Example 1:

A 20 kg child presents with first episode NS.

• Daily dose: 2 mg/kg = 40 mg daily × 6 weeks.

• Then alternate-day: 1.5 mg/kg = 30 mg on alternate days × 6 weeks.

• Total course: 12 weeks.

Avoid: tapering below alternate day dose before completion of 12 weeks — increases relapse.

2. Relapsing Nephrotic Syndrome

a. Infrequent Relapser

• <2 relapses in 6 months or <3 in 1 year.

Dose:

Prednisolone 2 mg/kg/day until remission (urine protein nil/trace × 3 days),
then 1.5 mg/kg on alternate days for 4 weeks, then stop.

Example:
Child relapses after 5 months remission → give daily 2 mg/kg till protein nil ×3 days → shift to 1.5 mg/kg AD ×4 weeks → stop.

b. Frequent Relapser

• ≥2 relapses in 6 months or ≥4 in 12 months.

Dose:
Same as above for each relapse, but consider tapering or steroid-sparing agent.

Maintenance (if steroid-only used):

Alternate day 0.5–0.7 mg/kg prednisolone for 3–6 months.

Example:
If child relapses every 2 months — after inducing remission, maintain on 0.5 mg/kg AD for 6 months to break cycle.

c. Steroid-Dependent Nephrotic Syndrome (SDNS)

• Relapse during tapering or within 2 weeks of stopping steroids.

Strategy 1: Low-dose alternate-day steroids

Maintain remission with 0.3–0.5 mg/kg AD for 6–12 months.

Strategy 2: Add steroid-sparing agent

Cyclophosphamide, levamisole, MMF, or calcineurin inhibitor depending on toxicity and previous exposure.

Example:
A 7-year-old develops relapse each time dose falls below 0.5 mg/kg AD → maintain at 0.5 mg/kg AD × 6 months; if Cushingoid, add levamisole.

d. Steroid-Resistant Nephrotic Syndrome (SRNS)

• No remission after 6 weeks of daily 2 mg/kg prednisolone.

Confirm compliance, dose accuracy, and rule out secondary NS before labeling SRNS.

Protocol:

Continue same dose for total 6–8 weeks before biopsy and calcineurin inhibitor introduction.

Example:
A 6-year-old on pred 2 mg/kg × 6 weeks still 3+ protein — if compliance ensured, classify as SRNS, proceed to biopsy.

3. Partial Responders or Slow Responders

If urine protein reduces but not nil after 6 weeks →
continue full dose 2 mg/kg/day for additional 2 weeks before deciding resistance.

4. Relapse While on Alternate-Day Therapy

Switch to 2 mg/kg/day until remission × 3 days,
then back to alternate-day baseline dose for 4 weeks.

5. Relapse While on Daily Steroid (e.g., during infection)

Do not increase dose; continue same daily dose until infection settles.
After remission, taper normally.

6. Special Scenarios

a. Grossly Edematous Child

• Use IV methylprednisolone (10–15 mg/kg/day × 3 days) if poor oral absorption suspected, then switch to oral 2 mg/kg/day.

• Confirm no hypovolemia before diuretics.

b. Infantile Nephrotic Syndrome (<1 yr)

• Usually genetic; steroid trial limited: 2 mg/kg/day × 6 weeks, but if no response by 4 weeks, stop (to avoid toxicity).

c. Secondary NS (e.g., lupus, infection-related)

• Dosing guided by underlying disease.

• Lupus NS: 2 mg/kg/day (max 60 mg) × 4 weeks + taper; or IV methylpred pulses.

7. Tapering Protocols – Practical Pearls

Avoid abrupt stop:

Always taper after alternate-day phase, not during daily phase.

Example – Extended taper for high-risk relapser:

After 6+6 weeks:

• Reduce to 1 mg/kg AD × 2 weeks

• Then 0.5 mg/kg AD × 2 weeks

• Then stop.

Taper traps:

8. Toxicity Prevention

9. Transition to Steroid-Sparing Agents (for practice)

10. Practical MD-Level Scenarios & Solutions

11. Key Pharmacologic Notes

• Bioavailability: Prednisolone preferred (not deflazacort for initial induction).

• Equivalent doses: 5 mg prednisolone = 4 mg methylpred = 0.75 mg dexamethasone.

• Morning dosing preferable to preserve circadian rhythm.

12. Reference Sources

1. Kliegman RM, Nelson Textbook of Pediatrics, 22nd ed., Elsevier, 2023.

2. KDIGO Glomerular Diseases Guideline, 2021.

3. Indian Pediatrics Nephrology Group, Consensus Statement on Management of Nephrotic Syndrome, 2021.

4. IPNA Clinical Practice Recommendations for Idiopathic NS, 2020.

5. Avner ED et al., Pediatric Nephrology, 8th ed. (RPS, 2022).

Table of Contents(toc)

When a young child comes in with cough, difficulty breathing, and fever, one of the most important — and sometimes confusing — clinical questions is:

Is this bronchiolitis, pneumonia, or something else entirely?

1. Age and Season — The First Clues

According to Nelson, bronchiolitis is primarily a disease of infants, typically below 2 years of age, with the peak incidence between 2–6 months. It usually appears during the winter and early spring months, corresponding to RSV season.

Pneumonia, on the other hand, can occur in all age groups. Viral pneumonias are more common in infants and preschoolers, while bacterial pneumonias increase with age. There’s no strict seasonal restriction, though viral etiologies may peak in winter.

2. Etiology — The Culprit Behind It

• Bronchiolitis:
  Caused most commonly by Respiratory Syncytial Virus (RSV) — responsible for the majority of cases in infants. Other causes include parainfluenza, influenza, human metapneumovirus, and adenovirus.

• Pneumonia:

  • Viral — RSV, influenza, parainfluenza, adenovirus.

  • Bacterial — Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus, and Mycoplasma pneumoniae (in older children).

In short, RSV = bronchiolitis, while bacterial pathogens = pneumonia is a good starting point, though overlap exists.

3. Pathophysiology — Where the Problem Lies

Nelson emphasizes that the site of pathology differentiates the two:

• Bronchiolitis: Inflammation and edema of small airways (bronchioles) → obstruction → air trapping, atelectasis, and wheeze.

• Pneumonia: Involves alveoli → consolidation, impaired gas exchange, and reduced compliance.

So, in bronchiolitis, the problem is in airflow, whereas in pneumonia, it’s in oxygen exchange.

4. Clinical Features — The Real Diagnostic Key

In bronchiolitis, wheezing and hyperinflation dominate; in pneumonia, crackles and focal findings dominate.

5. Chest X-ray — Helpful but Not Always Diagnostic

Nelson advises that radiologic findings should not be used in isolation to differentiate.
However, classic patterns help:

• Bronchiolitis: Hyperinflated lungs, flattened diaphragm, peribronchial thickening, patchy atelectasis — no focal consolidation.

• Pneumonia: Lobar or segmental consolidation, air bronchograms, or patchy infiltrates.

6. Response to Therapy

Another practical clue from Nelson:

• Bronchiolitis: Poor response to antibiotics; supportive care is the mainstay (hydration, oxygen if hypoxemic).

• Pneumonia: Marked improvement with appropriate antibiotics if bacterial.

7. Common Differentials (Nelson Mentions)

Nelson lists several conditions that mimic bronchiolitis or pneumonia:

1. Asthma (viral-induced wheeze):

   • Often recurrent episodes.

   • Family/personal history of atopy or asthma.

   • Responds well to bronchodilators, unlike classic bronchiolitis.

2. Pertussis:

   • Paroxysmal cough, inspiratory “whoop,” vomiting after coughing.

   • Minimal wheeze, may have leukocytosis with lymphocytosis.

3. Foreign Body Aspiration:

   • Sudden onset, unilateral decreased air entry, localized hyperinflation or collapse.

4. Congestive Heart Failure:

   • Tachypnea, hepatomegaly, but no true wheezing unless pulmonary edema present.

   • Cardiomegaly on chest X-ray.

5. Aspiration Pneumonitis / GER-related:

   • History of vomiting, feeding difficulty, neurological disease.

   • Recurrent or persistent infiltrates in dependent lung areas.

8. Management Overview (as per Nelson)

• Bronchiolitis:

  • Supportive: Oxygen, hydration, nasal suctioning.

  • Avoid routine bronchodilators, steroids, antibiotics.

  • Hospitalization: If severe distress, apnea, poor feeding, or SpO₂ < 90%.

• Pneumonia:

  • Empiric antibiotics based on age and likely pathogen.

  • Supportive care: Oxygen, fluids, antipyretics.

9. Key Takeaway from Nelson

“Bronchiolitis should be suspected in infants with their first episode of wheezing following a viral prodrome, whereas pneumonia should be suspected in the presence of fever, focal crackles, and signs of consolidation.”

In practice, overlap exists — especially when viral pneumonia blurs the line — but understanding age, pattern, and auscultatory findings helps steer the diagnosis right.

10. Summary Table

References

• Nelson Textbook of Pediatrics, 21st Edition, Chapters 390 (Bronchiolitis) and 391 (Pneumonia).

• Nelson Essentials of Pediatrics, 9th Edition, Section: Respiratory Disorders in Children.

Umbilical Vein Catheterization (UVC) Notes for Medical students and Graduates

a child with umbilical vein catheter insitu cc by 4 wikimedia

Purpose:

• For vascular access in neonates (especially preterm or critically ill).

• Used for fluid, blood, medication administration, exchange transfusion, and central venous pressure (CVP) monitoring.

Indications

• Emergency vascular access in neonates

• Exchange transfusion

• Administration of IV fluids, parenteral nutrition, inotropes, or antibiotics

• Blood sampling or transfusion

• Monitoring of central venous pressure

Contraindications

• Omphalitis or periumbilical infection

• Peritonitis

• Necrotizing enterocolitis (NEC)

• Umbilical or portal vein thrombosis

• Imperforate or absent umbilical vein

Anatomical Background

• Umbilical vein: single, large, thin-walled vessel at 12 o’clock position in the umbilical stump.

• Leads to left portal vein → ductus venosus → inferior vena cava.

• Two smaller umbilical arteries at 4 and 8 o’clock positions.

Equipment

• Sterile gloves, drapes, antiseptic solution

• Umbilical catheter (3.5 Fr for <1.5 kg, 5 Fr for >1.5 kg)

• Sterile scissors, forceps, and sutures

• 3-way stopcock and syringes

• Normal saline for flush

• Adhesive tape and umbilical tie

• Sterile dressing

Procedure Steps

1. Preparation

• Maintain aseptic technique.

• Place baby under radiant warmer.

• Monitor heart rate, SpO₂, and temperature.

• Restrain limbs gently.

2. Identify Vessels

• Clean umbilical stump with antiseptic.

• Trim cord to ~1–2 cm from skin margin.

• Identify one large thin-walled umbilical vein (12 o’clock) and two smaller thick-walled arteries (4 and 8 o’clock).

3. Catheter Measurement

• Measure insertion length:

  • Formula (Shukla’s):
    [
    Length (cm) = (3 × weight [kg]) + 9 text{ cm (for term)}
    ]
    or
    [
    Length (cm) = (1.5 × birthweight [kg]) + 5.6 text{ cm (for preterm)}
    ]

  • Aim: tip at IVC–right atrial junction (high position).

4. Catheter Insertion

• Tie umbilical tape loosely at the base of the cord.

• Gently dilate the vein with forceps.

• Insert catheter filled with saline (to prevent air embolism).

• Advance slowly until free blood return is obtained.

• For emergency use, low position (2–4 cm) acceptable until radiographic confirmation.

5. Confirmation of Position

• Aspirate blood freely (should not be pulsatile).

• X-ray (AP chest–abdomen) to confirm tip location:

  • High position: at T8–T9 (just above diaphragm).

  • Low position: at L3–L4 (below liver).

6. Secure Catheter

• Tie umbilical tape firmly around cord.

• Apply sterile dressing and tape catheter to abdomen.

• Connect to infusion system with 3-way stopcock.

7. Documentation

• Record catheter size, insertion length, date/time, and tip level on X-ray.

Complications

Early:

• Malposition → hepatic or portal vein perforation

• Air embolism

• Arrhythmia

• Bleeding or hematoma

• Infection (omphalitis, sepsis)

Late:

• Thrombosis or embolism

• Portal hypertension

• Hepatic necrosis

• Catheter-related bloodstream infection

Prevention and Care

• Strict asepsis

• Confirm tip location before infusion of irritants

• Daily check for signs of infection or leakage

• Remove within 7–10 days (preferably <5 days)

Radiologic Tip Positions

Key Notes

• Never use arterial catheter for IV infusion — risk of gut necrosis.

• Flush catheter with saline to confirm patency before use.

• If resistance is met → stop and recheck direction; never force insertion.

• In case of doubt, remove and reattempt under sterile precautions.